New insights into the role of TREM2 in Alzheimer's disease
Alzheimer's disease (AD) is the leading cause of dementia. The two histopathological
markers of AD are amyloid plaques composed of the amyloid-β (Aβ) peptide, and …
markers of AD are amyloid plaques composed of the amyloid-β (Aβ) peptide, and …
[HTML][HTML] Current understanding of RANK signaling in osteoclast differentiation and maturation
JH Park, NK Lee, SY Lee - Molecules and cells, 2017 - Elsevier
Osteoclasts are bone-resorbing cells that are derived from hematopoietic precursor cells
and require macrophage-colony stimulating factor and receptor activator of nuclear factor-κB …
and require macrophage-colony stimulating factor and receptor activator of nuclear factor-κB …
TREM2 in neurodegenerative diseases
TR Jay, VE von Saucken, GE Landreth - Molecular neurodegeneration, 2017 - Springer
TREM2 variants have been identified as risk factors for Alzheimer's disease (AD) and other
neurodegenerative diseases (NDDs). Because TREM2 encodes a receptor exclusively …
neurodegenerative diseases (NDDs). Because TREM2 encodes a receptor exclusively …
TREM2 variants: new keys to decipher Alzheimer disease pathogenesis
Genome-wide association studies have identified rare variants of the gene that encodes
triggering receptor expressed on myeloid cells 2 (TREM2)—an immune receptor that is …
triggering receptor expressed on myeloid cells 2 (TREM2)—an immune receptor that is …
Osteoclast multinucleation: review of current literature
J Kodama, T Kaito - International journal of molecular sciences, 2020 - mdpi.com
Multinucleation is a hallmark of osteoclast maturation. The unique and dynamic
multinucleation process not only increases cell size but causes functional alterations …
multinucleation process not only increases cell size but causes functional alterations …
TREM2-ligand interactions in health and disease
The protein triggering receptor expressed on myeloid cells-2 (TREM2) is an
immunomodulatory receptor with a central role in myeloid cell activation and survival. In …
immunomodulatory receptor with a central role in myeloid cell activation and survival. In …
Cutting edge: TREM-2 attenuates macrophage activation
IR Turnbull, S Gilfillan, M Cella, T Aoshi… - The Journal of …, 2006 - journals.aai.org
The triggering receptor expressed on myeloid cells 2 (TREM-2) delivers intracellular signals
through the adaptor DAP12 to regulate myeloid cell function both within and outside the …
through the adaptor DAP12 to regulate myeloid cell function both within and outside the …
Common signalling pathways in macrophage and osteoclast multinucleation
M Pereira, E Petretto, S Gordon… - Journal of cell …, 2018 - journals.biologists.com
Macrophage cell fusion and multinucleation are fundamental processes in the formation of
multinucleated giant cells (MGCs) in chronic inflammatory disease and osteoclasts in the …
multinucleated giant cells (MGCs) in chronic inflammatory disease and osteoclasts in the …
Multinucleated giant cells: current insights in phenotype, biological activities, and mechanism of formation
K Ahmadzadeh, M Vanoppen, CD Rose… - Frontiers in cell and …, 2022 - frontiersin.org
Monocytes and macrophages are innate immune cells with diverse functions ranging from
phagocytosis of microorganisms to forming a bridge with the adaptive immune system. A …
phagocytosis of microorganisms to forming a bridge with the adaptive immune system. A …
TREM2-and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1
Q Peng, S Malhotra, JA Torchia, WG Kerr… - Science …, 2010 - science.org
The activation and fusion of macrophages and of osteoclasts require the adaptor molecule
DNAX-activating protein of 12 kD (DAP12), which contains immunoreceptor tyrosine-based …
DNAX-activating protein of 12 kD (DAP12), which contains immunoreceptor tyrosine-based …